Carfilzomib: a novel treatment in relapsed and refractory multiple myeloma

por Fostier, Karel, De Becker, Ann, Schots, Rik
Publicado 2012

A case report of immunosuppression-related Kaposi’s sarcoma after autologous stem cell transplantation

por Heyrman, Bert, De Becker, Ann, Schots, Rik
Publicado 2016

Efficacy of high-dose anakinra in refractory macrophage activation syndrome in adult-onset Still’s disease: when dosage matters in overcoming secondary therapy resistance

por Ajeganova, Sofia, De Becker, Ann, Schots, Rik
Publicado 2020

End-of-life decision-making across cancer types: results from a nationwide retrospective survey among treating physicians

por Verkissen, Mariëtte N., Houttekier, Dirk, Cohen, Joachim, Schots, Rik, Chambaere, Kenneth, Deliens, Luc
Publicado 2018

Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation

por Fostier, Karel, Caers, Jo, Meuleman, Nathalie, Broos, Katrijn, Corthals, Jurgen, Thielemans, Kris, Schots, Rik, De Keersmaecker, Brenda
Publicado 2018

Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma

por Wang, Jinheng, Faict, Sylvia, Maes, Ken, De Bruyne, Elke, Van Valckenborgh, Els, Schots, Rik, Vanderkerken, Karin, Menu, Eline
Publicado 2016

Liquid Biopsy-Derived DNA Sources as Tools for Comprehensive Mutation Profiling in Multiple Myeloma: A Comparative Study

por Heestermans, Robbe, De Brouwer, Wouter, Maes, Ken, Vande Broek, Isabelle, Vaeyens, Freya, Olsen, Catharina, Caljon, Ben, De Becker, Ann, Bakkus, Marleen, Schots, Rik, Van Riet, Ivan
Publicado 2022

Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts

por Faict, Sylvia, Muller, Joséphine, De Veirman, Kim, De Bruyne, Elke, Maes, Ken, Vrancken, Louise, Heusschen, Roy, De Raeve, Hendrik, Schots, Rik, Vanderkerken, Karin, Caers, Jo, Menu, Eline
Publicado 2018

The Transfer of Sphingomyelinase Contributes to Drug Resistance in Multiple Myeloma

por Faict, Sylvia, Oudaert, Inge, D’Auria, Ludovic, Dehairs, Jonas, Maes, Ken, Vlummens, Philip, De Veirman, Kim, De Bruyne, Elke, Fostier, Karel, Vande Broek, Isabelle, Schots, Rik, Vanderkerken, Karin, Swinnen, Johannes V., Menu, Eline
Publicado 2019

The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic

por Bieghs, Liesbeth, Lub, Susanne, Fostier, Karel, Maes, Ken, Van Valckenborgh, Els, Menu, Eline, Johnsen, Hans E., Overgaard, Michael T., Larsson, Olle, Axelson, Magnus, Nyegaard, Mette, Schots, Rik, Jernberg-Wiklund, Helena, Vanderkerken, Karin, De Bruyne, Elke
Publicado 2014

Preclinical Evaluation of Invariant Natural Killer T Cells in the 5T33 Multiple Myeloma Model

por Nur, Haneen, Fostier, Karel, Aspeslagh, Sandrine, Renmans, Wim, Bertrand, Elisabeth, Leleu, Xavier, Favreau, Mérédis, Breckpot, Karine, Schots, Rik, De Waele, Marc, Van Valckenborgh, Els, De Bruyne, Elke, Facon, Thierry, Elewaut, Dirk, Vanderkerken, Karin, Menu, Eline
Publicado 2013

Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis: A case series and literature review

por van Dijk, Myrthe J., van Oirschot, Brigitte A., Stam‐Slob, Manon C., Waanders, Esmé, van der Zwaag, Bert, van Beers, Eduard J., Jans, Judith J. M., van der Linden, Peter Willem, Torregrosa Diaz, Jose M., Gardie, Betty, Girodon, François, Schots, Rik, Thielen, Noortje, van Wijk, Richard
Publicado 2022